Regulatory Open Forum

 View Only
Expand all | Collapse all

eIFU for Breast Implants in EU

  • 1.  eIFU for Breast Implants in EU

    Posted 27-May-2021 12:17
    Dear community

    I would like to ask you to share your experiences related to provide breast implant devices into the EU market with eIFU instead of a paper IFU. Is this possible, according to regulations available and from the Notified Bodies perspective?

    Thank you!


    ------------------------------
    C.Oviedo
    Sr. RA Specialist
    ------------------------------


  • 2.  RE: eIFU for Breast Implants in EU

    Posted 27-May-2021 13:43
    Yes, for the EU market, breast implants are eligible for provision of eIFU instead of paper IFU.  This is pursuant to the eIFU Regulation 207/2012 Article 3(1)(b).

    And this remains the case in the new implementing regulation that has been drafted (i.e., not yet entered into force) by the Commission laying down rules regarding eIFU for the application of Regulation (EU) 2017/745.

    ------------------------------
    Kevin Randall, ASQ CQA, RAC (Europe, U.S., Canada)
    Principal Consultant
    Ridgway, CO
    United States
    © Copyright 2021 by ComplianceAcuity, Inc. All rights reserved.
    ------------------------------



  • 3.  RE: eIFU for Breast Implants in EU

    Posted 28-May-2021 03:52
    Hi, 

    Kevin is right and gave references to the Regulation providing the basis for this. 
    The Regulation also defines all the requirements that apply to an eIFU solution. They are important as Notified Bodies will verify compliance with these requirements. 

    Best regards,

    ------------------------------
    Dirk Stynen PhD
    President
    QARAD
    Belgium
    dirk.stynen@qarad.com
    https://www.qarad.com/e-labeling-eifu
    ------------------------------



  • 4.  RE: eIFU for Breast Implants in EU

    Posted 31-May-2021 06:00
    Hi,

    Just wanted to add a note, we live in the 21st century and dealing with 10+ languages for translations many opt for eIFU across the board.  The regulation 207/2012 only applies for certain types of medical devices, implants being one of those eligible, so use caution when applying this to any medical device as your organisation can be challenged.  The EU MDR regulation 2017/745 points back to regulation 207/2012 so plan to have "discussions" with your Notified Body if applying eIFUs for other type of products not on the so-called eligible list.  The EU MDR itself is contradictory because if you read 23.1 it basically says if you have a website you must keep an electronic copy there, with no direct linkage to 207/2012 or section 23.1(f), and no apparent provisions for allowing eIFUs for any other devices as regulation 207/2012 is for specific devices.  EU Commission first needs to step into the electronic age of the internet and second needs to update their regulation from 2012 (which in real time could have been written in 1880) to current industry practices.  (And I still love the definition of a 'fixed installed medical device' chuckle)  I just bring this up because we have many companies asking in they can do eIFU in Europe for their products since its common practice now in 2021 in many other regions especially with translating into 10+ languages.

    ------------------------------
    Richard Vincins RAC
    Vice President Global Regulatory Affairs
    Oriel STAT A MATRIX - ENTERPRISE
    ------------------------------



  • 5.  RE: eIFU for Breast Implants in EU

    Posted 31-May-2021 16:27
    Edited by Reuben Lidster 31-May-2021 16:27
    Hear!  Hear!​

    ------------------------------
    Reuben Lidster
    Regulatory Affairs Specialist
    Bloomington IN
    United States
    ------------------------------



  • 6.  RE: eIFU for Breast Implants in EU

    Posted 31-May-2021 17:21
    Edited by Kevin Randall 31-May-2021 17:25
    1. Regulation 207/2012 applies to all medical devices.
    2. Its provisions for providing eIFU instead of paper IFU only apply to certain devices, specifically those listed in Article 3 therein.  No medical devices other than those encompassed by Article 3 are allowed to have eIFU instead of paper IFU.
    3. Whenever eIFU are provided in addition to paper IFU, whether that be for the Article 3 devices or for any other medical devices, then pursuant to Regulation 2017/745 (the "EU MDR") Annex 1 section 23.1, first paragraph, indent (f), then that must be done in accordance with the corresponding provisions of Regulation 207/2012.  Yet indent (f) also blankets the provision pf eIFU instead of paper IFU where such provision is allowed by Regulation 207/2012.
    4. This means that for EU MDR Annex I section 23.1 first paragraph demanding that certain parts of the IFU (not the entire IFU) be placed on the website if the manufacturer has a website, then such eIFU must for any medical device be paired with paper IFU in accordance with the corresponding provisions of Regulation 207/2012 unless the device is an Article 3 device for which Regulation 207/2012's requirements have been met for providing eIFU instead of paper IFU.
    5. This interpretation has been verified with the European Commission during my related correspondence with them.  Indeed, this interpretation seems to be the only logical interpretation allowed by Regulation 2017/745.  And this interpretation is maintained in the aforementioned draft regulation (with one potential exception not relevant to the current discussion).  I don't believe, and I don't think that the European Commission believes, that there is a conflict between Regulation 207/2012 and Regulation 2017/745, nor within Regulation 2017/745.  Accordingly, it's better for us to do our best at understanding these requirements in their current legislative forms, as it doesn't appear that they will be changed.


    ------------------------------
    Kevin Randall, ASQ CQA, RAC (Europe, U.S., Canada)
    Principal Consultant
    Ridgway, CO
    United States
    © Copyright 2021 by ComplianceAcuity, Inc. All rights reserved.
    ------------------------------



  • 7.  RE: eIFU for Breast Implants in EU

    Posted 01-Jun-2021 03:58
    Hi Kevin,

    I would have to politely disagree with your point 1.  No where in 207/2012 or 2017/745 does it say eIFUs can apply to all medical devices.  I can agree Article 1 of 207/2012 could be inferred broadly to any medical device.  However, there can be and is still broad interpretations based on the convoluted wording in the regulations.  My issue with eIFU use is: continue to have long "conversations" with auditors about this because there is such variation of interpretation when a minor nonconformity is being issued.  In fact, even last week working with a client where their Authorised Representative (AR) refused their Technical Documentation because they only had an eIFU for their implant and the AR stated that was not possible. I just take a strong point on this because I continually see pages and pages of IFUs of Class I, IIa, IIb products of 10 languages which are well established, well known, and the users of these device never, ever look at the IFUs - ends up with all the other waste.  And a strong point because I recognise this waste of paper, continued destruction of our rain forests, and we should be preventing use, not just saying oh these can be recycled.  My stance is the EU Commission needs to stop being bureaucratic and as they state their intent about supporting the planet should take a proactive approach to write clear regulations allowing a risk-based approach of eIFUs of all medical devices to reduce, recycle, and remove paper generation.

    ------------------------------
    Richard Vincins RAC
    Vice President Global Regulatory Affairs
    Oriel STAT A MATRIX - ENTERPRISE
    ------------------------------



  • 8.  RE: eIFU for Breast Implants in EU

    Posted 01-Jun-2021 09:26
    It is very disappointing indeed that the new draft eIFU reguation does not significantly expand the use of eIFU to other medical device categories. Missed opportunity.

    ------------------------------
    Dirk Stynen PhD
    President
    QARAD
    Belgium
    dirk.stynen@qarad.com
    https://www.qarad.com/e-labeling-eifu
    ------------------------------



  • 9.  RE: eIFU for Breast Implants in EU

    Posted 06-Jun-2021 10:09
    It is also disappointing that the new draft eIFU regulation does not address medical device software used exclusively by professionals on mobile devices only. In 2012 it may not have been foreseeable that such software products would be available. However almost ten years later, the premise that manufacturers need to expend considerable resources to justify not providing a paper IFU for these products evokes at best bemusement from users. Even for PACS systems on workstations, in over ten years at my last company, not one single user ever requested a paper IFU.

    ------------------------------
    Jean Bigoney PhD, RAC, CQE
    Senior Regulatory Affairs Specialist
    Morrisville NC
    United States
    ------------------------------



  • 10.  RE: eIFU for Breast Implants in EU

    Posted 01-Jun-2021 12:43
    Edited by Kevin Randall 01-Jun-2021 12:43

    Hi Richard.  I always appreciate your comments.  I would suggest that you reconsider your disagreement with point 1 (the European Commission's position on the matter).  A compliance strategy based on such a position is sure to lead to compliance problems.

    Remember that the EU MDR plainly states that instructions for use may be provided to the user in non-paper format (e.g. electronic), but only under the conditions set out in Regulation (EU) No 207/2012.  Remember also that Regulation 207/2012 identifies two categories of devices:  1) Those encompassed within Article 3; and 2) those not encompassed within Article 3.  Then that Regulation goes on to specify the conditions to be met whenever IFU are provided electronically.  Those conditions are generally broken down into two routes: a) provision of eIFU instead of paper (only the Article 3 devices are eligible for this route); and b) provision of eIFU in addition to paper (any device is eligible for that route).  Because of these parameters, the Commission would surely not agree that "…nowhere in 207/2012 or 2017/745 does it say eIFUs can apply to all medical devices…".  Indeed, EU MDR Annex I 23.1(h) plainly states just that.

    For example, during correspondence with the Commission, I asked, "...REGULATION (EU) No 207/2012 preface item (9), and Article 1 (second paragraph), and Article 9, specify requirements to be met when medical device instructions for use are provided in electronic form in addition to paper form.  Do these Article 1 (second paragraph) and Article 9 requirements apply to all medical devices, or instead only to the particular devices listed in Article 3?..."

    The Directorate General for Health and Food Safety's reply:  "...COMMISSION REGULATION (EU) No 207/2012 applies to all medical devices which have instructions for use provided electronically, regardless of whether they also provide paper format or if they benefit from...the use of electronic instead of paper format..." [emphasis added]

    The EU MDR can certainly be difficult to understand at times.  Nonetheless, given the significant impact of our footprints on the businesses and communities we affect, it is crucial that we achieve accurate understanding.  Misinterpretations can do severe damage, and even put lives at risk.



    ------------------------------
    Kevin Randall, ASQ CQA, RAC (Europe, U.S., Canada)
    Principal Consultant
    Ridgway, CO
    United States
    © Copyright 2021 by ComplianceAcuity, Inc. All rights reserved.
    ------------------------------



  • 11.  RE: eIFU for Breast Implants in EU

    Posted 05-Jun-2021 07:54
    Hi All, 

    I participate in MedTech Europe's Labeling/eIFU subworkgroup, and although we have worked diligently with industry and in presenting our position to the COM, there is still active resistance to expanding the scope of eIFU. Primarily they cite lack of evidence demonstrating that safe use can be extended to other device types, and indicate that they want to review studies conducted in the EU with EU users with other types of devices. There appears to be one main resistant member of the Commission, and no others that feel the need to push the issue. Although we are committed to continuing to pursue avenues to persuade the EC to increase the eIFU scope, the timeline is definitely on the scale of "years" before we see doing so.

    ------------------------------
    Kathleen Crowder
    Sr. Mgr., Regulatory Affairs
    Baxter Healthcare
    Lake Zurich IL
    United States
    ------------------------------



  • 12.  RE: eIFU for Breast Implants in EU

    Posted 05-Jun-2021 10:17
    Hi Kathleen, 

    It is great to see this contribution by a member of MedTech Europe's subworkgroup on this topic. I only wish you had more encouraging news :-). 

    My company started commercializing a web platform for eIFU more than 10 years ago, first for IVD and later for MD. About 100 companies use our service. If our vast experience can be of any help in MedTech Europe's initiatives to extend the scope for eIFU, do not hesitate to contact me.

    ------------------------------
    Dirk Stynen PhD
    President
    QARAD
    Belgium
    dirk.stynen@qarad.com
    https://www.qarad.com/e-labeling-eifu
    ------------------------------



  • 13.  RE: eIFU for Breast Implants in EU

    Posted 09-Jun-2021 11:29
    Thank you Richard

    I agree with you, the regulation could be more clear on this topic and also updated to current user needs, possibilities and practices. There are still doubts in how and when is possible to implement the eIFU.

    However, I have not seen a contradiction on this topic in MDR. I interpret section 23.1 (General) as it asking manufacturers for having an electronic copy of the DFU in the company website without this electronic copy be a replacement of the paper format DFU. Being 23.1 (f) specific in case manufactures want to replace the paper format by another format such electronic, and here MDR links the possibility of using eIFU instead of paper eIFU to the corresponding regulation.



    ------------------------------
    C.Oviedo
    RA Executive
    ------------------------------



  • 14.  RE: eIFU for Breast Implants in EU

    Posted 08-Jun-2021 09:35
    Thank you Dirk.

    We have reviewed the regulation, but we still find some interested parties that disagree regarding the possibility of using eIFU for Breast Implants.


    ------------------------------
    C.Oviedo
    RA Executive
    ------------------------------



  • 15.  RE: eIFU for Breast Implants in EU

    Posted 08-Jun-2021 09:50
    Hi Carolina, 

    I'd love to see those interested parties' arguments. For me, it is candid clear that eIFU are possible for CE marked breast implants in the EU, but it is always good to listen to other peoples' arguments.

    ------------------------------
    Dirk Stynen PhD
    President
    QARAD
    Belgium
    dirk.stynen@qarad.com
    https://www.qarad.com/e-labeling-eifu
    ------------------------------



  • 16.  RE: eIFU for Breast Implants in EU

    Posted 08-Jun-2021 09:28
    Thank you Kevin!

    ------------------------------
    C.Oviedo
    RA Executive
    ------------------------------



  • 17.  RE: eIFU for Breast Implants in EU

    Posted 09-Jun-2021 04:03
    Dear All

    Please be aware of the release of the draft for the electronic instructions.
    https://ec.europa.eu/info/law/better-regulation/have-your-say/initiatives/12954-Medical-devices-online-manuals-replacing-paper-instructions_en
    The new implementing regulation expands the scope of the Regulation to include medical device software as well as the MDR is included.

    I would also be interested why breast implants would not qualify.

    Article 3 of the Draft
    1. Manufacturers may provide instructions for use in electronic form instead of in paper form where those instructions relate to any of the following devices:

      1. (a)  implantable and active implantable medical devices and their accessories covered by Regulation (EU) 2017/745;

      2. (b)  fixed installed medical devices covered by Regulation 2017/745;

      3. (c)  medical devices and their accessories covered by Regulation (EU) 2017/745 and fitted with a built-in system visually displaying the instructions for use.



    Best Regards
    Stephanie

    ------------------------------
    Stephanie Grassmann
    Managing Director of MedTechXperts Ltd
    Biberstein
    Switzerland
    ------------------------------



  • 18.  RE: eIFU for Breast Implants in EU

    Posted 09-Jun-2021 12:00
    @Stephanie Grassmann, thanks for sharing the link to the eIFU regulation draft. 

    @Dirk Stynen, @Stephanie Grassmann regarding why breast implants would not qualify, It have not been received a clearly reason on why not, but a negative position on the possibility of implementing it. This is the reason why I asked this foro to share experiences and knowledge on this topic, to have a broader vision of the correct interpretation of the available regulations.


    ​​​​​​

    ------------------------------
    C.Oviedo
    RA Executive
    ------------------------------



  • 19.  RE: eIFU for Breast Implants in EU

    Posted 10-Jun-2021 03:03
    Potential reasons why one would oppose the use of eIFU for breast implants might be: 
    - the wish to sell the products into markets that do not accept eIFU at all. 
    - selling the breast implants for esthetic purposes only and not for medical purposes. In that case they would not have been subject to the Medical Device Directive. I admit that I do not even know if that would be possible. I am not an expert on the regulation for such devices. Even if that would be a (theoretical?) possibility under the MD Directive, it is not the case any more as implants for esthetic purposes are now covered by the Medical Device Regulation under Annex XVI. That argument does not count anymore. 

    These are just guesses. It would be great to learn the arguments of those interested parties and see if they can be anwered. 


    ------------------------------
    Dirk Stynen PhD
    President
    QARAD
    Belgium
    dirk.stynen@qarad.com
    https://www.qarad.com/e-labeling-eifu
    ------------------------------